[Prediction of overactive bladder treatment outcome by using long-term urodynamics]

Area of Science:

• Urology
• Pharmacology

Background:

• Overactive bladder (OAB) affects millions over 40, with current treatments including anticholinergics and beta-3-receptor agonists.
• Low compliance with OAB medication (around 40% after 4 months) is linked to a high rate of non-responders.
• Effective OAB treatment relies on identifying detrusor overactivity (DO), but standard urodynamics have a low detection rate for DO.

Purpose of the Study:

• To investigate a novel method for detecting detrusor overactivity (DO) to improve overactive bladder (OAB) treatment targeting.
• To assess the potential of the Wille Capsule (WiCa) for enhanced DO detection.

Main Methods:

• Utilized the Wille Capsule (WiCa) in an in vitro experimental model.
• Monitored for detrusor overactivity (DO) over a 72-hour period.

Main Results:

• Successfully detected detrusor overactivity (DO) using the Wille Capsule (WiCa) in an in vitro setting.
• The 72-hour detection window offers a prolonged observation period for DO.

Conclusions:

• The Wille Capsule (WiCa) demonstrates potential for improved detection of detrusor overactivity (DO).
• Enhanced DO detection could lead to more targeted and effective overactive bladder (OAB) treatments.
• This approach may positively impact patient compliance with OAB therapies.